Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-26
DOI
10.3389/fphar.2018.00032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic
- (2018) John L. Wallace et al. ANTIOXIDANTS & REDOX SIGNALING
- Cardiotoxicity and Oncological Treatments
- (2018) Axel Schlitt et al. Deutsches Arzteblatt International
- Cancer as a Risk Factor for Cardiovascular Disease
- (2017) Dana Elena Giza et al. Current Oncology Reports
- Gas signaling molecule hydrogen sulfide attenuates doxorubicin-induced dilated cardiomyopathy
- (2017) Zongliang Yu et al. Oncotarget
- Hydrogen Sulfide Inhibits High-Salt Diet-Induced Myocardial Oxidative Stress and Myocardial Hypertrophy in Dahl Rats
- (2017) Pan Huang et al. Frontiers in Pharmacology
- Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
- (2017) Runmin Guo et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
- (2017) Liqun Zhao et al. Scientific Reports
- From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
- (2017) Carlo Gabriele Tocchetti et al. ANTIOXIDANTS & REDOX SIGNALING
- Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
- (2016) Roberto Marques Damiani et al. ARCHIVES OF TOXICOLOGY
- Prevention of cardiotoxicity among survivors of childhood cancer
- (2016) Kelley K. Hutchins et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
- (2016) Giuseppe Curigliano et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Vascular Toxicities of Cancer Therapies
- (2016) Joerg Herrmann et al. CIRCULATION
- Cardio-Oncology
- (2016) Carrie G. Lenneman et al. CIRCULATION RESEARCH
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Myricitrin Protects against Doxorubicin-Induced Cardiotoxicity by Counteracting Oxidative Stress and Inhibiting Mitochondrial Apoptosis via ERK/P53 Pathway
- (2016) Jing Sun et al. Evidence-based Complementary and Alternative Medicine
- Nature creates adapts protects and sustains life using hydrogen sulfide
- (2016) Siamak Tabibzadeh Frontiers in Bioscience-Landmark
- Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway
- (2016) MI-HUA LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy
- (2016) Clelia Madeddu et al. Journal of Cardiovascular Medicine
- H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance
- (2016) Konstantin Chegaev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hydrogen Sulfide: Biogenesis, Physiology, and Pathology
- (2016) Jin-Song Bian et al. Oxidative Medicine and Cellular Longevity
- Physiological Importance of Hydrogen Sulfide: Emerging Potent Neuroprotector and Neuromodulator
- (2016) Sandesh Panthi et al. Oxidative Medicine and Cellular Longevity
- The Role of Hydrogen Sulfide in Evolution and the Evolution of Hydrogen Sulfide in Metabolism and Signaling
- (2016) Kenneth R. Olson et al. PHYSIOLOGY
- An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures
- (2016) George J. Dugbartey et al. TOXICOLOGY
- Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity
- (2016) J Wu et al. Cell Death & Disease
- Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management
- (2016) Michael E. Layoun et al. Current Oncology Reports
- H2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair
- (2016) Matteo Ciocci et al. Oncotarget
- Progress and Prospects in Pediatric Leukemia
- (2016) P. Pallavi Madhusoodhan et al. Current Problems in Pediatric and Adolescent Health Care
- The Role of Hydrogen Sulfide in Renal System
- (2016) Xu Cao et al. Frontiers in Pharmacology
- Drug-induced mitochondrial dysfunction and cardiotoxicity
- (2015) Zoltán V Varga et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiovascular Disease in Adult Survivors of Childhood Cancer
- (2015) Steven E. Lipshultz et al. Annual Review of Medicine
- Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux
- (2015) Hong Xie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemotherapy-induced cardiomyopathy
- (2015) Angela Y. Higgins et al. HEART FAILURE REVIEWS
- Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes
- (2015) MI-HUA LIU et al. Molecular Medicine Reports
- Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting calreticulin expression in H9c2 cells
- (2015) MI-HUA LIU et al. Molecular Medicine Reports
- Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting the expression of peroxiredoxin III in H9c2 cells
- (2015) MI-HUA LIU et al. Molecular Medicine Reports
- Gasotransmitters in cancer: from pathophysiology to experimental therapy
- (2015) Csaba Szabo NATURE REVIEWS DRUG DISCOVERY
- Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter
- (2015) John L. Wallace et al. NATURE REVIEWS DRUG DISCOVERY
- The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential
- (2015) Yaqi Shen et al. Oxidative Medicine and Cellular Longevity
- Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
- (2015) Paweorn Angsutararux et al. Oxidative Medicine and Cellular Longevity
- Hydrogen sulfide in pharmacology and medicine – An update
- (2015) Jerzy Bełtowski Pharmacological Reports
- Hydrogen sulfide and cardioprotection — Mechanistic insights and clinical translatability
- (2015) Fadi N. Salloum PHARMACOLOGY & THERAPEUTICS
- Hydrogen sulfide and polysulfides as signaling molecules
- (2015) Hideo KIMURA PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications
- (2014) Yu Zhao et al. CHEMICAL COMMUNICATIONS
- Induction of MicroRNA-21 With Exogenous Hydrogen Sulfide Attenuates Myocardial Ischemic and Inflammatory Injury in Mice
- (2014) S. Toldo et al. Circulation-Cardiovascular Genetics
- Hydrogen Sulfide and Endothelial Dysfunction: Relationship with Nitric Oxide
- (2014) Zaid Altaany et al. CURRENT MEDICINAL CHEMISTRY
- Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin
- (2014) Jenelle Govender et al. JOURNAL OF PINEAL RESEARCH
- A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
- (2014) Anne Polk et al. BMC Pharmacology & Toxicology
- Cardiovascular Toxicities from Systemic Breast Cancer Therapy
- (2014) Shuang Guo et al. Frontiers in Oncology
- Garlic and cardioprotection: insights into the molecular mechanisms
- (2013) Tarak Nath Khatua et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells
- (2013) RUNMIN GUO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The role of autophagy in doxorubicin-induced cardiotoxicity
- (2013) Amie J. Dirks-Naylor LIFE SCIENCES
- Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells
- (2013) RUN-MIN GUO et al. Molecular Medicine Reports
- Cyclophosphamide-Associated Cardiotoxicity in a Child after Stem Cell Transplantation for β-Thalassemia Major: Case Report and Review of the Literature
- (2013) Emily E. Meserve et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Cardiotoxicity in childhood cancer survivors: A problem with long-term consequences in need of early detection and prevention
- (2013) Steven E. Lipshultz et al. PEDIATRIC BLOOD & CANCER
- Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy
- (2011) C. Panis et al. BREAST CANCER RESEARCH AND TREATMENT
- Anthracycline cardiotoxicity
- (2011) Pierantonio Menna et al. Expert Opinion On Drug Safety
- Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity
- (2011) Anna Tesei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress
- (2011) Xiu-Yu Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- S-diclofenac Protects against Doxorubicin-Induced Cardiomyopathy in Mice via Ameliorating Cardiac Gap Junction Remodeling
- (2011) Huili Zhang et al. PLoS One
- Hydrogen sulfide: its production, release and functions
- (2010) Hideo Kimura AMINO ACIDS
- Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage
- (2010) Carrie Anna Geisberg et al. CURRENT HYPERTENSION REPORTS
- Hydrogen Sulfide Regulates Cardiac Function and Structure in Adriamycin-Induced Cardiomyopathy
- (2009) Yu-Wen Su et al. CIRCULATION JOURNAL
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search